Lakefront Biotherapeutics (LKFT) Goodwill (2014 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly Goodwill of $3.2 million for Q1 2026, down 95.63% year-over-year from $73.3 million in Q1 2025, and down 8.22% quarter-over-quarter from $3.5 million in Q4 2025.
Lakefront Biotherapeutics (LKFT) Goodwill (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Goodwill for 13 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill fell 95.63% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 95.63% YoY), while the FY2025 annual figure was $3.5 million, down 95.34% from the prior year.
- Goodwill slipped to $3.2 million in Q1 2026 per LKFT's latest filing, from $3.5 million in the prior quarter.
- Across five years, Goodwill topped out at $78.3 million in Q2 2025 and bottomed at -$1.9 million in Q1 2022.
- Historically, Goodwill has averaged $52.6 million across 5 years, with a median of $74.8 million in 2023.
- Annual changes were most pronounced in 2023 — Goodwill soared 4047.3% — and 2026, when it plunged 95.63%.
- Lakefront Biotherapeutics' Goodwill stood at $71.2 million in 2022, then increased by 5.07% to $74.8 million in 2023, then retreated by 0.04% to $74.8 million in 2024, then plunged by 95.34% to $3.5 million in 2025, then fell by 8.22% to $3.2 million in 2026.
- Business Quant data shows LKFT's Goodwill at $3.2 million in Q1 2026, $3.5 million in Q4 2025, and $3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lakefront Biotherapeutics | 1.81 Bn | -1.68 Bn | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.20 Mn |
| Dec 31, 2025 | 3.49 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Jun 30, 2025 | 78.28 Mn |
| Mar 31, 2025 | 73.33 Mn |
| Dec 31, 2024 | 74.81 Mn |
| Sep 30, 2024 | 76.29 Mn |
| Mar 31, 2024 | 75.74 Mn |
| Dec 31, 2023 | 74.84 Mn |
| Sep 30, 2023 | 76.05 Mn |
| Mar 31, 2023 | 74.78 Mn |
| Dec 31, 2022 | 71.23 Mn |
| Mar 31, 2022 | -1.89 Mn |
| Dec 31, 2021 | -1.97 Mn |
| Jun 30, 2021 | -2.88 Mn |
| Dec 31, 2020 | -3.80 Mn |
| Jun 30, 2020 | -821,689.26 |
| Mar 31, 2020 | -731,911.57 |
| Dec 31, 2019 | -1.26 Mn |
| Sep 30, 2019 | -1.41 Mn |